Filing Flows › Repligen (RGEN) › Capital expenditures
Repligen (RGEN) capital expenditures by quarter
Repligen's capital expenditures were $4.9M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 7 quarters it ranged from $3.6M (Q1 2025) to $8.2M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $4.9M | -7% | +5% |
| Q2 2026 | $5.3M | +13% | -25% |
| Q1 2026 | $4.7M | -42% | +32% |
| Q4 2025 | $8.2M | +73% | — |
| Q3 2025 | $4.7M | -34% | — |
| Q2 2025 | $7.1M | +99% | — |
| Q1 2025 | $3.6M | — | — |
Q3 2026 at a glance
Repligen, Q3 2026: revenue $209M (+11% year over year), operating margin -14.1%, net loss $38.4M, operating cash flow $43.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Repligen's capital expenditures?
Repligen's capital expenditures were $4.9M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has Repligen's capital expenditures changed?
Over the last 7 quarters it ranged from $3.6M (Q1 2025) to $8.2M (Q4 2025).